The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 bindingP B Fischer(University of Oxford), Frances M. Platt(University of Oxford)Journal of VirologySeptember 1, 199510.1128/jvi.69.9.5791-5797.1995Cited by 155SaveCiteExport RISWatch citationsRelated PapersUnbiased yeast screens identify cellular pathways affected in Niemann–Pick disease type C|Life Science Alliance|2020|15Dysregulation of the NLRP3 Inflammasome and Promotion of Disease by IL-1β in a Murine Model of Sandhoff Disease|Cells|2025|1